Atlas Trials

AnaptysBio, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AnaptysBio, Inc.

RecordFirmDate
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) (NCT06127043)AnaptysBio, Inc.2023-12-04
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) (NCT06041269)AnaptysBio, Inc.2023-08-31
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD). (NCT05935085)AnaptysBio, Inc.2023-06-13
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (NCT05205070)AnaptysBio, Inc.2021-12-22
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (NCT03614923)AnaptysBio, Inc.2018-11-29
Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (NCT03533751)AnaptysBio, Inc.2018-06-19
Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma (NCT03469934)AnaptysBio, Inc.2017-11-14

Track AnaptysBio, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.